| scholarly article | Q13442814 |
| P2093 | author name string | Zheng Gong | |
| Zhaoyu Liu | |||
| Ziwen Wang | |||
| Yuan Chi | |||
| He Xin | |||
| P2860 | cites work | The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation | Q28507317 |
| Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms | Q29615455 | ||
| Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments | Q33616887 | ||
| Long noncoding RNA in liver diseases | Q33946469 | ||
| Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation | Q34042260 | ||
| Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis | Q35086389 | ||
| Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size | Q36231054 | ||
| A feed-forward loop between lncARSR and YAP activity promotes expansion of renal tumour-initiating cells | Q37464844 | ||
| Long Non-Coding RNA Profiling in a Non-Alcoholic Fatty Liver Disease Rodent Model: New Insight into Pathogenesis | Q37631409 | ||
| MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway | Q38297030 | ||
| Genome-wide analysis of long noncoding RNA expression profiles in patients with non-alcoholic fatty liver disease | Q38456347 | ||
| Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA. | Q38775160 | ||
| LATS2-mediated YAP1 phosphorylation is involved in HCC tumorigenesis | Q38875112 | ||
| MicroRNA Regulates Hepatocytic Differentiation of Progenitor Cells by Targeting YAP1. | Q41144036 | ||
| Long Noncoding RNA lncARSR Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Modulating PTEN-PI3K/Akt Pathway. | Q48206950 | ||
| Pathogenesis of non-alcoholic fatty liver disease mediated by YAP. | Q50057357 | ||
| Hippo-mediated suppression of IRS2/AKT signaling prevents hepatic steatosis and liver cancer | Q50199746 | ||
| Metformin improves hepatic IRS2/PI3K/Akt signaling in insulin-resistant rats of NASH and cirrhosis | Q50250304 | ||
| Subchronic cadmium exposure upregulates the mRNA level of genes associated to hepatic lipid metabolism in adult female CD1 mice. | Q51735656 | ||
| Long noncoding RNA lncARSR promotes hepatic lipogenesis via Akt/SREBP-1c pathway and contributes to the pathogenesis of nonalcoholic steatohepatitis. | Q52648157 | ||
| Insulin receptor substrate 2: a bridge between Hippo and AKT pathways. | Q55308130 | ||
| Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence | Q56341421 | ||
| lncARSR promotes liver cancer stem cells expansion via STAT3 pathway | Q58584151 | ||
| LncRNA-AK012226 Is Involved in Fat Accumulation in db/db Mice Fatty Liver and Non-alcoholic Fatty Liver Disease Cell Model | Q58795421 | ||
| Effects of daphnetin on lipid metabolism, insulin resistance and oxidative stress in OA‑treated HepG2 cells. | Q64944611 | ||
| Intensive insulin treatment induces insulin resistance in diabetic rats by impairing glucose metabolism-related mechanisms in muscle and liver | Q84539920 | ||
| Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease | Q89220189 | ||
| Knockdown of Orphan Transporter SLC22A18 Impairs Lipid Metabolism and Increases Invasiveness of HepG2 Cells | Q91011762 | ||
| Yes-associated protein promotes early hepatocyte cell cycle progression in regenerating liver after tissue loss | Q91443850 | ||
| Pinolenic acid ameliorates oleic acid-induced lipogenesis and oxidative stress via AMPK/SIRT1 signaling pathway in HepG2 cells | Q92727951 | ||
| P433 | issue | 1 | |
| P921 | main subject | metabolic dysfunction–associated steatotic liver disease | Q1546498 |
| fatty liver disease | Q6058862 | ||
| P304 | page(s) | 126 | |
| P577 | publication date | 2020-03-13 | |
| P1433 | published in | Journal of Translational Medicine | Q15716664 |
| P1476 | title | Long noncoding RNA lncARSR promotes nonalcoholic fatty liver disease and hepatocellular carcinoma by promoting YAP1 and activating the IRS2/AKT pathway | |
| P478 | volume | 18 |
| Q94671270 | Long noncoding RNA lncARSR confers resistance to Adriamycin and promotes osteosarcoma progression | cites work | P2860 |
Search more.